TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Women With HER2-Positive Breast Cancer Brain Metastases
Conditions: Breast Cancer; Brain Metastases; HER2-positive Breast Cancer; CNS Disease Interventions: Drug: Tucatinib; Drug: Pembrolizumab; Drug: Trastuzumab Sponsors: Reva Basho; Merck Sharp & Dohme Corp.; Seattle Genetics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Genetics | HER2 | Herceptin | Neurology | Research | Women